The TanDerm System is a one-step topical delivery system in packette
form that permits combination therapy by segregating diverse drug products until use for
in-situ interaction of these drugs. The convenience of this delivery system facilitates
patient compliance in combination therapies that would otherwise be more complicated to
administer. The intellectual property underlying the TanDerm System is patent
protected under the following U.S. Patents: 5,242,433; 5,470,323; and 5,460,620.
Quinnova is currently working with its Scientific Advisory Board and consultants to identify drug product candidates utilizing the TanDerm Delivery System.